409:
1640:
and the
Michigan Gastrointestinal Peptide Research Center, Ann Arbor, MI 48109, USA Division of Gastroenterology, Department of Pediatrics, VA Medical Center and University of Michigan, and the Michigan Gastrointestinal Peptide Research Center, Ann Arbor, MI 48109, USA Division of Gastroenterology, Department of Internal Medicine, VA Medical Center and University of Michigan, and the Michigan Gastrointestinal Peptide Research Center, Ann Arbor, MI 48109, USA Kochman, Michael Lee DelValle, John Dickinson, Chris John Boland, C. Richard (2006-04-10).
516:(c-Src) is activated in colon cancer cells and leads to increased amounts of hPG80. This means that hPG80 production, which occurs during early tumorigenesis, could play a role in this activation, which is known as an early event in colon tumorigenesis. The PI3K/Akt pathway, which is particularly involved in proliferation, is also activated by hPG80. NF-kappaB is another important signaling messenger regulated by hPG80. Its involvement in mechanisms responsible for the anti-apoptotic effect of hPG80 has been demonstrated in
626:. Thus, several types of tumors express the unmatured peptide. hPG80 can be detected and quantified in the blood of cancer patients. A first demonstration has been made in colorectal cancer showing an increase of hPG80 and non-amide gastrin levels in plasma in these patients compared to a control series (healthy individuals). In addition, an hPG80 increase has been observed in patients with adenomatous polyps. hPG80 is therefore expressed at all stages by the tumor, from early stages to metastasis.
635:
504:, respectively, and abrogated by inhibition of PI3K. Thus, constitutive activation of the Wnt pathway, considered to be at the onset of tumorigenesis in the colon, and the K-Ras oncogene, present in 50% of human colorectal tumors, synergistically stimulate the production of hPG80, a tumorigenesis promoter. Tumorigenesis induced by activation of the Wnt pathway is partially dependent on hPG80.
22:
565:
binding of progastrin to certain cell lines (IEC-6, IEC-18, HT-29, COLO320) was also detected. A specificity of binding was confirmed by competition with cold, unlabelled hPG80, but not with carboxy-terminal glycine-containing gastrin or amidated gastrin-17. Binding was not influenced by the presence of the classical CCK-2 receptor.
590:, those from GPCR56-deficient mice (GPCR56-/-) are resistant to hPG80. However, although hPG80 has been shown to bind to cells expressing GPCR56, authors did not provide direct evidence of a hPG80 bound to GPCR56 itself. GPCR56 is a good candidate, but evidence that it is hPG80 receptor is to this day not established.
1639:
Division of
Gastroenterology, Department of Internal Medicine, VA Medical Center and University of Michigan, and the Michigan Gastrointestinal Peptide Research Center, Ann Arbor, MI 48109, USA Division of Gastroenterology, Department of Internal Medicine, VA Medical Center and University of Michigan,
568:
It is clear from these two studies that there is a binding site/receptor for hPG80 that is distinct from binding to gastrin-17 amidated and to gastrin 17 with carboxy-terminal glycine (G17-Gly). The sequence of hPG80 interacting with this receptor is likely located in the last 26 amino acid residues
499:
expression, the hypothesis of a possible cooperation between these two pathways to regulate hPG80 expression was investigated. Chakadar and al. found significant synergistic stimulation of the GAST gene promoter (by a factor of 25–40) by a combination of oncogenic β-catenin and K-Ras overexpression.
564:
High affinity binding sites have been described for the first time in intestinal epithelial cells using recombinant human progastrin iodine. Affinity was in the range of 0.5-1 nM, which is receptor compatible. When biotinylated progastrin binding was evaluated by flow cytometry, strong and specific
560:
An identification of the hPG80 receptor has been the subject of several studies in recent years. However, hPG80 receptor identity remains a real issue in the scientific community. The receptor can activate a number of signaling pathways, either directly or indirectly, which is rather unusual for a
719:
In addition, earlier detection of small lesions and monitoring of recurrence can be improved by measuring hPG80 levels as a complementary blood biomarker in a cohort of patients with hepatocellular carcinoma treated with local or systemic therapies (Fig. 3). Measured hPG80 levels are relevant in
419:(CSCs) constitute a small proportion of the tumor, usually between 1 and 5%. But they are essential for tumor survival because they act as a "reactor". Giraud and al. have demonstrated the major role played by hPG80 in CSCs. These authors have shown that hPG80 expression is strongly increased in
187:
The name hPG80 was thus proposed in the publication resulting from the work of
Professor Benoît You under the management of Dominique Joubert and Alexandre Prieur in order to remove ambiguities between the intracellular version of the protein (in the function of digestion) and its extracellular
581:
cells. In addition, annexin A2 may be involved in progastrin-dependent clathrin endocytosis. However, progastrin affinity for
Annexin A2 is not what would be expected for a specific receptor. And, although Annexin A2 plays a role in progastrin functions, it does not fit a receptor function.
435:
cells implanted mice are treated in vivo with such an antibody, CSCs frequency is decreased in the same proportions. These two scientific articles clearly show that hPG80 is a survival factor for CSCs. Moreover, hPG80 inhibition would induce CSC differentiation, opening the possibility of a
339:
gene or neutralization of hPG80 resulted in a decrease in the number of tumors in mice with a tumor predisposition (mutation on the APC gene). Conversely, a significant increase in tumor formation was observed in mice overexpressing progastrin and treated with azoxymethane (AOM), a chemical
2657:
Ottewell, P. D.; Varro, A.; Dockray, G. J.; Kirton, C. M.; Watson, A. J. M.; Wang, T. C.; Dimaline, R.; Pritchard, D. M. (2005). "COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo".
2890:
Caplin, M.E.; Savage, K.; Khan, K.; Rode, J.; Brett, B.; Varro, A.; Michaeli, D.; Pounder, R.E.; Dhillon, A.P. (1998). "Expression and processing of gastrin in patients with hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma".
1296:
Chakladar, Abhijit; Dubeykovskiy, Alexander; Wojtukiewicz, Lindsay J.; Pratap, Jitesh; Lei, Shi; Wang, Timothy C. (October 2005). "Synergistic activation of the murine gastrin promoter by oncogenic Ras and β-catenin involves SMAD recruitment".
561:
receptor. This could indicate a peculiarity of this receptor and why it is difficult to identify it. The unidentified hPG80 receptor transduces a progastrin signal via various intracellular intermediates known to be involved in tumorigenesis.
352:. In 2015, hPG80 was shown to be a pro-angiogenic factor. Indeed, hPG80 stimulates endothelial cells proliferation and migration and increases their ability to form capillary-like structures in vitro. Blocking the production of hPG80 (with
163:
is secreted by tumor cells and found in the plasma of cancer patients from early stages. It then has functions that are independent of digestion and totally different from progastrin and its only role as an intracellular precursor of
1969:
Singh, Pomila; Velasco, Marco; Given, Randall; Wargovich, Michael; Varro, Andrea; Wang, Timothy C. (2000-03-01). "Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM".
426:
under conditions where CSCs are enriched. They then showed that hPG80 was able to regulate CSCs frequency (survival and self-renewal) in vitro and in vivo. Subsequently, Prieur and al. demonstrated that when a neutralizing
715:
In addition, You and al. observed a decrease in hPG80 levels after surgery in a patients cohort with gastrointestinal cancers with peritoneal involvement treated with post-operative chemotherapy and cytoreductive surgery.
309:. This work showed that hPG80 measurement more accurately reflected tumor than the conventional measurement of amide gastrin. Indeed, hPG80 is more than 700 times more abundant than amide gastrin in colorectal tumors.
1578:
Prieur, Alexandre; Cappellini, Monica; Habif, Guillaume; Lefranc, Marie-Paule; Mazard, Thibault; Morency, Eric; Pascussi, Jean-Marc; Flacelière, Maud; Cahuzac, Nathalie; Vire, Bérengère; Dubuc, Benjamin (2017-06-09).
320:
function of hPG80 in tumor cells. Generally, it has been shown that hPG80 does not mature properly in cancer cells, particularly in colorectal cancer, because maturation enzymes are either absent or non-functional.
292:
2020: hPG80 is detected in the plasma of patients with 11 different types of cancer. An association between longitudinal variations in hPG80 levels and the efficacy of anti-cancer treatments has been demonstrated.
2021:
Wu, Hai; Owlia, Azarmidokht; Singh, Pomila (December 2003). "Precursor peptide progastrin1-80 reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP".
1347:
Pannequin, Julie; Delaunay, Nathalie; Buchert, Michael; Surrel, Fanny; Bourgaux, Jean–François; Ryan, Joanne; Boireau, Stéphanie; Coelho, Jessica; Pélegrin, André; Singh, Pomila; Shulkes, Arthur (November 2007).
3009:
Paterson, Adrienne C; Macrae, Finlay A; Pizzey, Cathy; Baldwin, Graham S; Shulkes, Arthur (2014-02-19). "Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma".
724:(AFP) is below 20 ng/ml, an established threshold in clinical practice. Depending on disease management, patients in remission have lower levels of hPG80 than those in whom the cancer is still active.
585:
Another candidate is the G protein-coupled receptor 56 (GPCR56), expressed on both colon stem cells and cancer cells. While human recombinant hPG80 promotes in vitro growth and survival of wild mice colon
572:
One candidate is
Annexin A2, identified as being able of binding progastrin and derived peptides. Annexin A2 is a partial mediator of the effect of progastrin/gastrins. In particular, Annexin A2 mediates
2549:
Singh, P.; Lu, X.; Cobb, S.; Miller, B. T.; Tarasova, N.; Varro, A.; Owlia, A. (2003-02-01). "Progastrin1–80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites".
305:
as a model. Bardram was the first to hypothesize the presence of hPG80 in the early stages of the disease. He evaluated the presence of hPG80 and its maturation products in the serum of patients with
312:
In the early 90s, it was shown that hPG80 was not fully matured in human colon cancer cell lines and, more importantly, that it was secreted by in vitro cells. These observations led to the study of
400:
allows restoration of membrane localization of tight and adherent junctions constituent proteins in a human colorectal carcinoma cell line DLD-1. hPG80 thus plays a role on cell contacts integrity.
818:
You, Benoit; Mercier, Frédéric; Assenat, Eric; Langlois-Jacques, Carole; Glehen, Olivier; Soulé, Julien; Payen, Léa; Kepenekian, Vahan; Dupuy, Marie; Belouin, Fanny; Morency, Eric (January 2020).
2068:
Westwood, David A; Patel, Oneel; Christophi, Christopher; Shulkes, Arthur; Baldwin, Graham S (2017-04-21). "Progastrin: a potential predictive marker of liver metastasis in colorectal cancer".
1044:
Singh, P.; Xu, Z.; Dai, B.; Rajaraman, S.; Rubin, N.; Dhruva, B. (1994-03-01). "Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins".
500:
Activation of the GAST gene promoter was also shown to be dependent on other signalling signals: enhanced or suppressed by co-expression of wild-type SMAD4 or by a dominant negative mutant of
2345:
Ferrand, Audrey; Bertrand, Claudine; Portolan, Ghislaine; Cui, Guanglin; Carlson, Jane; Pradayrol, Lucien; Fourmy, Daniel; Dufresne, Marlene; Wang, Timothy C.; Seva, Catherine (2005-04-01).
1090:
Singh, P.; Owlia, A.; Varro, A.; Dai, B.; Rajaraman, S.; Wood, T. (1996-09-15). "Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells".
301:
Through a variety of mechanisms, all crucial for tumor growth and survival, research has demonstrated the major role that hPG80 plays in tumor initiation and progression, generally using
598:
hPG80 through various mechanisms can be considered as a major promoter of tumorigenesis. hPG80 is found in the plasma of cancer patients and its neutralization induces tumor reversion.
392:
Cell migration is based on their ability to become independent of adjacent cells. Intercellular contacts integrity is essential for electrolyte uptake regulation as well as for tumor
642:
hPG80 is found in different tumor types and secreted in vitro by certain cancer cells. A study has shown its presence in the blood of patients with 11 different types of cancer:
3226:
Kowalski-Chauvel, Aline; Gouaze-Andersson, Valerie; Vignolle-Vidoni, Alix; Delmas, Caroline; Toulas, Christine; Cohen-Jonathan-Moyal, Elizabeth; Seva, Catherine (2017-04-20).
2711:"Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells"
741:, appears to be a promising approach. The use of anti-hPG80 antibodies has also been discussed as a potential treatment in colorectal cancer patients with a mutation in the
2226:
1663:
1520:
Giraud, J.; Failla, L. M.; Pascussi, J.-M.; Lagerqvist, E. L.; Ollier, J.; Finetti, P.; Bertucci, F.; Ya, C.; Gasmi, I.; Bourgaux, J.-F.; Prudhomme, M. (2016-05-04).
1667:
1400:
Ramanathan, Vigneshwaran; Jin, Guangchun; Westphalen, Christoph
Benedikt; Whelan, Ashley; Dubeykovskiy, Alexander; Takaishi, Shigeo; Wang, Timothy C. (2012-04-05).
453:
The first event leading to colon cancer is in 80 to 90% of cases a constitutive activation of the Wnt/β-catenin oncogenic pathway induced by mutations in the APC (
638:
Figure 3 - Longitudinal changes in hPG80 and AFP levels during hepatocellular carcinoma management (inclusion; remission; progression) in a representative patient
2926:
Caplin, M.; Savage, K.; Khan, K.; Brett, B.; Rode, J.; Varro, A.; Dhillon, A. (2000-08-01). "Expression and processing of gastrin in pancreatic adenocarcinoma".
155:
A link between this protein and cancer has been known for more than 30 years. hPG80 is involved in most of the biological functions that ensure the existence of
524:
gene. JAK2 (Janus-activated kinase 2), STAT3 and kinases increases regulated by extracellular signals have also been observed in the colon mucosa of hGAS mice.
759:
This has recently been confirmed for ovarian, breast, esophageal, liver and gastric cancers making this therapeutic antibody a potential multi-cancer drug.
2823:
Jin, Guangchun; Sakitani, Kosuke; Wang, Hongshan; Jin, Ying; Dubeykovskiy, Alexander; Worthley, Daniel L.; Tailor, Yagnesh; Wang, Timothy C. (2017-03-23).
440:, which probably explains why this peptide can be considered as a potential predictive marker for the presence of liver metastasis in colorectal cancer.
1581:"Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer"
380:
activation and a decrease in DNA fragmentation. Therefore, the effect of hPG80 on cell survival results from both increased proliferation and decreased
1914:"Intestinal expression of mutant and wild-type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic mice"
2307:
Kondo, Jumpei; Powell, Anne E.; Coffey, Robert J. (2016). "466 Escape From BMP4-Mediated Growth
Suppression Is an Early Event in Colonic Neoplasia".
756:
3. decreased tumor burden and increased cell differentiation in the remaining tumors in transgenic mice developing Wnt-induced intestinal neoplasia.
2445:"Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo"
771:
factor that can be targeted to sensitize rectum radiation-resistant cancers. hPG80 decreased expression increases sensitivity to irradiation in
3118:
Do, Catherine; Bertrand, Claudine; Palasse, Julien; Delisle, Marie-Bernadette; Cohen-Jonathan-Moyal, Elizabeth; Seva, Catherine (2013-11-08).
540:
gene is repressed, inducing inactivation of the Notch pathway which plays a major role in the acquisition of a differentiated cell phenotype.
46:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
2994:
2825:"The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis"
569:
of hPG80 carboxy-terminal end, which have been shown to be sufficient for its function. However, this putative receptor identity is unknown.
1246:"pp60c-Src Kinase Mediates Growth Effects of the Full-Length Precursor Progastrin1–80 Peptide on Rat Intestinal Epithelial Cells, in Vitro"
247:
2003: hPG80 is involved in the dissociation regulation of adherent and tight junctions. Src mediates the effects of hPG80 on cell growth.
436:
differentiation therapy rather than a classical anti-proliferative therapy. Its main function is to help CSCs survive and spread to form
1186:"Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma"
117:
536:
cells which do not express hPG80 return to a "normal" state. This is due to the fact that when the Wnt pathway is inactivated, the
408:
694:
Pre- and post-operative plasma assays of hPG80 in colorectal cancer patients show that hPG80 presence reflects tumor production.
396:
prevention. In 2003, it was demonstrated that blocking hPG80 secretion by an antisense construction directed against progastrin
43:
137:. This name first appeared in a scientific publication in January 2020. Until that date, scientific publications only mention '
3061:
Do, C.; Bertrand, C.; Palasse, J.; Delisle, M.-B.; Shulkes, A.; Cohen-Jonathan-Moyal, E.; Ferrand, A.; Seva, C. (2012-02-24).
306:
753:
2. prolongation of in vitro and in vivo chemosensitivity and delayed relapse after treatment of T84 xenografted mouse cells;
240:
2000 - 2001: The GAST gene is a target of the β-catenin/Tcf4 pathway. The presence of hPG80 is demonstrated in the plasma of
820:"The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients"
457:) coding gene or the β-catenin coding gene. Mutations induction into normal intestinal stem cells is sufficient to trigger
2768:"Annexin A2 Mediates Up-regulation of NF-κB, β-catenin, and Stem Cell in Response to Progastrin in Mice and HEK-293 Cells"
2396:"Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor- B"
663:
196:
488:
expression are produced by activation of the Raf-MEK-ERK signal transduction pathway, final step being activation of the
39:
32:
55:
1350:"β-Catenin/Tcf-4 Inhibition After Progastrin Targeting Reduces Growth and Drives Differentiation of Intestinal Tumors"
348:
When a tumor develops, its need for oxygen and nutrients causes creation of new blood vessels. This process is called
152:
For more clarity, the remainder of this article uses exclusively the name hPG80 to refer to extracellular progastrin.
1681:
Van
Solinge, Wouter W.; Nielsen, Finn C.; Friis-Hansen, Lennart; Falkmer, Ursula G.; Rehfeld, Jens F. (April 1993).
98:
2502:"The Wnt Target Jagged-1 Mediates the Activation of Notch Signaling by Progastrin in Human Colorectal Cancer Cells"
454:
2178:"Oncogenic ras induces gastrin/CCKB receptor gene expression in human colon cancer cell lines LoVo and Colo320HSR"
552:
gene mutation was shown to increase hPG80-dependent colon cells proliferation and colon cancer formation in mice.
70:
2347:"Signaling Pathways Associated with Colonic Mucosa Hyperproliferation in Mice Overexpressing Gastrin Precursors"
882:"Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells"
188:
version of the protein (in the case of cancer patients) which is no longer, despite its name, the precursor of
328:
gene expression is required for human colon cancer cell tumorigenesis. 60 to 80% of colon cancers express the
2500:
Pannequin, J.; Bonnans, C.; Delaunay, N.; Ryan, J.; Bourgaux, J.-F.; Joubert, D.; Hollande, F. (2009-07-21).
1004:
van
Solinge, W. W.; Odum, L.; Rehfeld, J. F. (1993-04-15). "Ovarian cancers express and process progastrin".
77:
1402:"P53 Gene Mutation Increases Progastrin Dependent Colonic Proliferation and Colon Cancer Formation in Mice"
2176:
Hori, Hiroyuki Nakata, Hirohisa Iguchi, Genzo Yamada, Hajime
Chihara, Kazuo Baba, Hisamitsu (2010-04-01).
1522:"Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells"
1130:
Koh, Theodore J; Chen, Duan (September 2000). "Gastrin as a growth factor in the gastrointestinal tract".
697:
It has been observed that hPG80 concentrations are increased in patients at risk of developing colorectal
1912:
Cobb, Stephanie; Wood, Thomas; Ceci, Jeffrey; Varro, Andrea; Velasco, Marco; Singh, Pomila (2004-03-15).
2220:
634:
466:
258:
783:. In the same lineage, hPG80 targeting also results in radiation-induced survival pathways inhibition,
737:
To date, no drug is able to target CSCs. Humanized anti-hPG80 antibodies, alone or in combination with
84:
51:
3063:"A New Biomarker That Predicts Colonic Neoplasia Outcome in Patients with Hyperplastic Colonic Polyps"
2253:
945:
278:
2016: Autocrine secretion of hPG80 promotes survival and self-renewal of stem cells in colon cancer.
2600:
Dubeykovskiy, Alexander; Nguyen, Thomas; Dubeykovskaya, Zinaida; Lei, Shi; Wang, Timothy C. (2008).
47:
3293:
1816:"Expression of gastrin, gastrin/CCK-B- and gastrin/CCK-C. Receptors in human colorectal carcinomas"
513:
357:
317:
313:
66:
3100:
3043:
2959:
2872:
2766:
Sarkar, Shubhashish; Swiercz, Rafal; Kantara, Carla; Hajjar, Katherine A.; Singh, Pomila (2011).
2748:
2691:
2582:
2101:
2003:
1951:
1657:
1618:
1499:
1163:
911:
702:
361:
1460:
Najib, S; Kowalski-Chauvel, A; Do, C; Roche, S; Cohen-Jonathan-Moyal, E; Seva, C (2014-08-11).
176:
In the name hPG80, the "h" describes the human species: human; "PG" is a common script for the
3288:
3265:
3247:
3208:
3200:
3159:
3141:
3092:
3084:
3035:
3027:
2990:
2951:
2943:
2908:
2864:
2846:
2805:
2787:
2740:
2732:
2683:
2675:
2639:
2621:
2574:
2566:
2531:
2523:
2482:
2464:
2425:
2417:
2376:
2368:
2324:
2289:
2271:
2208:
2200:
2158:
2140:
2093:
2085:
2047:
2039:
1995:
1987:
1943:
1935:
1894:
1876:
1837:
1796:
1761:
1753:
1712:
1704:
1645:
1610:
1602:
1551:
1543:
1491:
1483:
1439:
1421:
1379:
1371:
1322:
1314:
1275:
1267:
1223:
1205:
1155:
1147:
1107:
1099:
1069:
1061:
1021:
1013:
981:
963:
903:
857:
839:
772:
721:
675:
651:
647:
614:
is not the only type of cancer to express hPG80. Its expression has also been demonstrated in
611:
533:
517:
432:
420:
416:
353:
302:
262:
241:
234:
223:
212:
1730:
Ciccotosto, Giuseppe D.; McLeish, Andrew; Hardy, Kenneth J.; Shulkes, Arthur (October 1995).
3255:
3239:
3190:
3149:
3131:
3074:
3019:
2982:
2935:
2900:
2854:
2836:
2795:
2779:
2722:
2667:
2629:
2613:
2558:
2513:
2472:
2456:
2407:
2358:
2316:
2279:
2261:
2192:
2148:
2132:
2077:
2031:
1979:
1925:
1884:
1868:
1827:
1788:
1743:
1694:
1592:
1533:
1473:
1429:
1413:
1361:
1306:
1257:
1213:
1197:
1139:
1053:
971:
953:
893:
847:
831:
784:
623:
286:
141:', without necessarily explicitly specifying whether it is intracellular (in the context of
768:
679:
2257:
2242:"Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis"
1732:"Expression, processing, and secretion of gastrin in patients with colorectal carcinoma"
949:
472:
Demonstration of the link between hPG80 and an oncogenic pathway has been described for
3260:
3227:
3154:
3119:
2859:
2824:
2800:
2767:
2634:
2601:
2477:
2444:
2153:
2120:
1889:
1856:
1434:
1401:
1218:
1185:
852:
819:
683:
671:
615:
469:
oncogenic pathway. It is a downstream target of the β-catenin/Tcf-4 signaling pathway.
458:
230:
2904:
2320:
2196:
2177:
1143:
3282:
3195:
3178:
2939:
2284:
2241:
1832:
1815:
1792:
1748:
1731:
1699:
1682:
976:
933:
655:
643:
578:
481:
397:
372:
Treatment of intestinal epithelial cells with hPG80 results in a significant loss of
3047:
2963:
2752:
2695:
2586:
2007:
1622:
1503:
1167:
915:
272:
gene mutation increases hPG80-dependent colonic proliferation and cancer formation.
3079:
3062:
2986:
2876:
2105:
1955:
738:
659:
423:
349:
91:
2518:
2501:
2412:
2395:
2363:
2346:
1983:
1597:
1580:
1538:
1521:
1057:
3104:
2783:
2617:
2602:"Flow cytometric detection of progastrin interaction with gastrointestinal cells"
1417:
1366:
1349:
1857:"Identification of progastrin derived peptides in colorectal carcinoma extracts"
835:
747:
gene. Targeting of hPG80 with the humanized anti-hPG80 antibody has been shown:
619:
1310:
3243:
2841:
2081:
437:
393:
200:
181:
177:
138:
134:
3251:
3228:"Targeting progastrin enhances radiosensitization of colorectal cancer cells"
3204:
3145:
3136:
3088:
3031:
2947:
2912:
2850:
2791:
2736:
2679:
2671:
2625:
2570:
2562:
2527:
2468:
2421:
2372:
2328:
2275:
2204:
2144:
2089:
2043:
2035:
1991:
1939:
1880:
1841:
1800:
1757:
1708:
1683:"Expression but incomplete maturation of progastrin in colorectal carcinomas"
1649:
1606:
1547:
1487:
1425:
1375:
1318:
1271:
1209:
1151:
1103:
1065:
1017:
967:
843:
1642:
Post-translational processing of gastrin in neoplastic human colonic tissues
780:
709:
698:
381:
377:
373:
142:
3269:
3212:
3163:
3096:
3039:
2955:
2868:
2809:
2744:
2727:
2710:
2687:
2643:
2578:
2535:
2486:
2429:
2380:
2212:
2162:
2097:
2051:
1999:
1947:
1614:
1555:
1495:
1443:
1383:
1326:
1279:
1262:
1245:
1227:
1159:
907:
861:
250:
2005: Ras and β-catenin/Tcf4 pathways induce synergistic activation of the
2293:
2266:
1898:
1765:
1716:
1111:
1073:
1025:
985:
958:
261:/β-catenin pathway inducing decreased growth and tumor differentiation in
2460:
2136:
1478:
1461:
667:
587:
574:
428:
282:
3120:"Activation of pro-oncogenic pathways in colorectal hyperplastic polyps"
1872:
1201:
229:
1996 - 1997: hPG80 is identified as necessary for the proliferation and
1930:
1913:
1855:
Nemeth, J; Taylor, B; Pauwels, S; Varro, A; Dockray, G J (1993-01-01).
1814:
Imdahl, A.; Eggstein, S.; Baldwin, G.S.; Farthmann, E.H. (April 1995).
750:
1. a decrease in the self-renewal capacity of CSCs of various origins;
189:
165:
160:
3023:
898:
881:
2660:
American Journal of Physiology. Gastrointestinal and Liver Physiology
2551:
American Journal of Physiology. Gastrointestinal and Liver Physiology
2024:
American Journal of Physiology. Gastrointestinal and Liver Physiology
1972:
American Journal of Physiology. Gastrointestinal and Liver Physiology
1046:
American Journal of Physiology. Gastrointestinal and Liver Physiology
180:
protein and the number 80 corresponds to the size of the protein: 80
156:
2977:
DuBois, Raymond N. (2009), "Cyclooxygenase-2 in Colorectal Cancer",
633:
501:
407:
219:
146:
1779:"Gastrin gene expression in human pancreatic and colon cancers".
577:
upregulation and β-catenin in response to progastrin in mice and
335:
Through different experimental configurations, alteration of the
195:
Moreover, the existence of a phonetically identical peptide, the
145:) or extracellular (circulating and detectable in plasma) in the
38:
Please help to demonstrate the notability of the topic by citing
743:
477:
473:
2981:, Berlin, Heidelberg: Springer Berlin Heidelberg, p. 799,
1244:
Brown, D.; Yallampalli, U.; Owlia, A.; Singh, P. (2003-01-01).
690:
hPG80 in residual disease surveillance and response to therapy.
3177:
Carr, Brian I; Pancoska, Petr; Branch, Robert A (2010-02-25).
776:
549:
269:
15:
2240:
Cartwright, C. A.; Meisler, A. I.; Eckhart, W. (1990-01-01).
1462:"Progastrin a new pro-angiogenic factor in colorectal cancer"
199:(proGRP), accentuated a possible confusion around the name
275:
2014: hPG80 is identified as a new pro-angiogenic factor.
2394:
Rengifo-Cam, W.; Umar, S.; Sarkar, S.; Singh, P. (2007).
701:. In addition, an increase in hPG80 has been observed in
932:
Bardram, L.; Hilsted, L.; Rehfeld, J. F. (1990-01-01).
254:
gene, contributing to possible neoplastic progression.
520:
cells in vitro and in vivo in mice overexpressing the
480:
mutations all had significantly higher levels of GAST
2443:
Umar, S; Sarkar, S; Cowey, S; Singh, P (2008-06-02).
285:
directed against hPG80 to target the Wnt pathway and
133:
refers to the extracellular and oncogenic version of
2121:"Stem vs non-stem cell origin of colorectal cancer"
1299:
Biochemical and Biophysical Research Communications
412:
Figure 2 - hPG80, Cornerstone in ongenetic pathways
2709:Singh, P; Wu, H; Clark, C; Owlia, A (2006-07-10).
775:cell lines leading to increased radiation-induced
257:2007: Inhibition of hPG80 expression inhibits the
3179:"Low alpha-fetoprotein hepatocellular carcinoma"
2246:Proceedings of the National Academy of Sciences
2185:The Journal of Laboratory and Clinical Medicine
938:Proceedings of the National Academy of Sciences
289:represents a new therapeutic track for cancer.
934:"Progastrin expression in mammalian pancreas"
465:gene which encodes hPG80 is activated by the
207:Chronology of scientific discoveries on hPG80
8:
2225:: CS1 maint: multiple names: authors list (
1662:: CS1 maint: multiple names: authors list (
495:Since both K-Ras and the Wnt pathway induce
2070:International Journal of Colorectal Disease
476:. Cell lines and colon cancer tissues with
3183:Journal of Gastroenterology and Hepatology
3012:Journal of Gastroenterology and Hepatology
1666:) CS1 maint: numeric names: authors list (
712:of liver metastasis in colorectal cancer.
3259:
3194:
3153:
3135:
3078:
2858:
2840:
2799:
2726:
2633:
2517:
2476:
2411:
2362:
2283:
2265:
2152:
1929:
1888:
1831:
1747:
1698:
1596:
1537:
1477:
1433:
1365:
1261:
1217:
975:
957:
897:
851:
431:is added to a cell culture or when human
118:Learn how and when to remove this message
795:
484:than wild type K-Ras. K-Ras effects on
2340:
2338:
2218:
2063:
2061:
1655:
1634:
1632:
1515:
1513:
1395:
1393:
1291:
1289:
444:hPG80 and oncogenic signaling pathways
1573:
1571:
1569:
1567:
1565:
1455:
1453:
1342:
1340:
1338:
1336:
1239:
1237:
1179:
1177:
7:
1125:
1123:
1121:
1085:
1083:
1039:
1037:
1035:
999:
997:
995:
927:
925:
875:
873:
871:
813:
811:
809:
807:
805:
803:
801:
799:
33:notability guideline for neologisms
767:It has been shown that hPG80 is a
324:In 1996, it was demonstrated that
218:1993 - 1994: hPG80 is secreted by
203:and the need for a specific name.
14:
508:SRC, PI3K/Akt, NF-kB and Jak/Stat
360:cells in nude mice reduces tumor
3196:10.1111/j.1440-1746.2010.06303.x
2940:10.1046/j.1365-2168.2000.01488.x
2119:Huels, D J; Sansom, O J (2015).
705:that have progressed to cancer.
20:
1184:Siddheshwar, R K (2001-01-01).
31:may not meet Knowledge (XXG)'s
3080:10.1158/1940-6207.capr-11-0408
2987:10.1007/978-3-540-47648-1_1436
1:
2905:10.1016/s0016-5085(98)84945-7
2519:10.1158/0008-5472.can-08-2409
2413:10.1158/0008-5472.can-07-1206
2364:10.1158/0008-5472.can-04-0978
2321:10.1016/s0016-5085(16)30451-6
2197:10.1016/S0022-2143(03)00021-0
1984:10.1152/ajpgi.2000.278.3.g390
1598:10.1158/1078-0432.ccr-17-0533
1539:10.1158/0008-5472.can-15-1497
1144:10.1016/s0167-0115(00)00176-2
1058:10.1152/ajpgi.1994.266.3.g459
763:Sensitization to radiotherapy
197:Pro-Gastrin Releasing Peptide
2784:10.1053/j.gastro.2010.08.054
2618:10.1016/j.regpep.2008.07.001
2191:(5). 神戸大学保健管理センター: 335–341.
1833:10.1016/0016-5085(95)26249-0
1793:10.1016/0016-5085(95)29280-2
1749:10.1016/0016-5085(95)90572-3
1700:10.1016/0016-5085(93)90279-l
1418:10.3109/07357907.2012.657814
1367:10.1053/j.gastro.2007.08.023
388:Regulation of cell junctions
880:Hollande, F. (2003-04-01).
836:10.1016/j.ebiom.2019.11.035
211:1990: hPG80 is secreted by
3310:
3067:Cancer Prevention Research
2928:British Journal of Surgery
1311:10.1016/j.bbrc.2005.08.061
664:non-small cell lung cancer
455:Adenomatous polyposis coli
307:Zollinger-Ellison syndrome
40:reliable secondary sources
29:The topic of this article
3244:10.18632/oncotarget.17274
2842:10.18632/oncotarget.16506
2125:British Journal of Cancer
2082:10.1007/s00384-017-2822-8
404:Role in cancer stem cells
3137:10.1186/1471-2407-13-531
2672:10.1152/ajpgi.00268.2004
2563:10.1152/ajpgi.00351.2002
2036:10.1152/ajpgi.00216.2003
1787:(4): A1246. April 1995.
1585:Clinical Cancer Research
686:(endometrial/cervical).
886:Journal of Cell Science
532:It has been shown that
2979:Encyclopedia of Cancer
2728:10.1038/sj.onc.1209798
1263:10.1210/en.2002-220501
728:Target to fight cancer
639:
630:Multi-cancer detection
413:
149:pathological setting.
2267:10.1073/pnas.87.2.558
959:10.1073/pnas.87.1.298
637:
594:Clinical Applications
411:
368:Anti-apoptotic factor
344:Pro-angiogenic factor
2461:10.1038/onc.2008.169
2137:10.1038/bjc.2015.214
1479:10.1038/onc.2014.255
1406:Cancer Investigation
708:hPG80 may also be a
3238:(35): 58587–58600.
2835:(25): 40606–40619.
2606:Regulatory Peptides
2258:1990PNAS...87..558C
1873:10.1136/gut.34.1.90
1202:10.1136/gut.48.1.47
1132:Regulatory Peptides
950:1990PNAS...87..298B
703:hyperplastic polyps
607:Universal biomarker
2030:(6): G1097–G1110.
1931:10.1002/cncr.20094
720:patients for whom
640:
414:
362:neovascularization
35:
3024:10.1111/jgh.12417
2996:978-3-540-36847-2
2778:(2): 583–595.e4.
2512:(15): 6065–6073.
2455:(42): 5599–5611.
2406:(15): 7266–7274.
1591:(17): 5267–5280.
1532:(12): 3618–3628.
1472:(24): 3120–3130.
1098:(18): 4111–4115.
899:10.1242/jcs.00321
773:colorectal cancer
722:alpha-fetoprotein
676:pancreatic cancer
652:esophageal cancer
648:colorectal cancer
624:pancreatic tumors
612:Colorectal cancer
518:pancreatic cancer
433:colorectal cancer
421:colorectal cancer
417:Cancer stem cells
303:colorectal cancer
287:cancer stem cells
281:2017: The use of
242:colorectal cancer
213:pancreatic cancer
128:
127:
120:
102:
30:
3301:
3274:
3273:
3263:
3223:
3217:
3216:
3198:
3189:(9): 1543–1549.
3174:
3168:
3167:
3157:
3139:
3115:
3109:
3108:
3082:
3058:
3052:
3051:
3006:
3000:
2999:
2974:
2968:
2967:
2934:(8): 1035–1040.
2923:
2917:
2916:
2893:Gastroenterology
2887:
2881:
2880:
2862:
2844:
2820:
2814:
2813:
2803:
2772:Gastroenterology
2763:
2757:
2756:
2730:
2706:
2700:
2699:
2666:(3): G541–G549.
2654:
2648:
2647:
2637:
2612:(1–3): 106–114.
2597:
2591:
2590:
2557:(2): G328–G339.
2546:
2540:
2539:
2521:
2497:
2491:
2490:
2480:
2440:
2434:
2433:
2415:
2391:
2385:
2384:
2366:
2357:(7): 2770–2777.
2342:
2333:
2332:
2315:(4): S102–S103.
2309:Gastroenterology
2304:
2298:
2297:
2287:
2269:
2237:
2231:
2230:
2224:
2216:
2182:
2173:
2167:
2166:
2156:
2116:
2110:
2109:
2076:(7): 1061–1064.
2065:
2056:
2055:
2018:
2012:
2011:
1978:(3): G390–G399.
1966:
1960:
1959:
1933:
1924:(6): 1311–1323.
1909:
1903:
1902:
1892:
1852:
1846:
1845:
1835:
1820:Gastroenterology
1811:
1805:
1804:
1781:Gastroenterology
1776:
1770:
1769:
1751:
1742:(4): 1142–1153.
1736:Gastroenterology
1727:
1721:
1720:
1702:
1693:(4): 1099–1107.
1687:Gastroenterology
1678:
1672:
1671:
1661:
1653:
1636:
1627:
1626:
1600:
1575:
1560:
1559:
1541:
1517:
1508:
1507:
1481:
1457:
1448:
1447:
1437:
1397:
1388:
1387:
1369:
1360:(5): 1554–1568.
1354:Gastroenterology
1344:
1331:
1330:
1293:
1284:
1283:
1265:
1241:
1232:
1231:
1221:
1181:
1172:
1171:
1127:
1116:
1115:
1087:
1078:
1077:
1052:(3): G459–G468.
1041:
1030:
1029:
1012:(8): 1823–1828.
1001:
990:
989:
979:
961:
929:
920:
919:
901:
892:(7): 1187–1197.
877:
866:
865:
855:
815:
733:Antibody therapy
350:neo-angiogenesis
263:intestinal tumor
123:
116:
112:
109:
103:
101:
60:
24:
23:
16:
3309:
3308:
3304:
3303:
3302:
3300:
3299:
3298:
3279:
3278:
3277:
3225:
3224:
3220:
3176:
3175:
3171:
3117:
3116:
3112:
3060:
3059:
3055:
3008:
3007:
3003:
2997:
2976:
2975:
2971:
2925:
2924:
2920:
2889:
2888:
2884:
2822:
2821:
2817:
2765:
2764:
2760:
2708:
2707:
2703:
2656:
2655:
2651:
2599:
2598:
2594:
2548:
2547:
2543:
2506:Cancer Research
2499:
2498:
2494:
2442:
2441:
2437:
2400:Cancer Research
2393:
2392:
2388:
2351:Cancer Research
2344:
2343:
2336:
2306:
2305:
2301:
2239:
2238:
2234:
2217:
2180:
2175:
2174:
2170:
2118:
2117:
2113:
2067:
2066:
2059:
2020:
2019:
2015:
1968:
1967:
1963:
1911:
1910:
1906:
1854:
1853:
1849:
1813:
1812:
1808:
1778:
1777:
1773:
1729:
1728:
1724:
1680:
1679:
1675:
1654:
1638:
1637:
1630:
1577:
1576:
1563:
1526:Cancer Research
1519:
1518:
1511:
1459:
1458:
1451:
1399:
1398:
1391:
1346:
1345:
1334:
1295:
1294:
1287:
1243:
1242:
1235:
1183:
1182:
1175:
1129:
1128:
1119:
1092:Cancer Research
1089:
1088:
1081:
1043:
1042:
1033:
1006:Cancer Research
1003:
1002:
993:
931:
930:
923:
879:
878:
869:
817:
816:
797:
793:
765:
735:
730:
692:
680:prostate cancer
632:
616:ovarian cancers
609:
604:
596:
558:
546:
530:
510:
492:gene promoter.
451:
446:
406:
390:
370:
346:
299:
209:
174:
124:
113:
107:
104:
61:
59:
37:
25:
21:
12:
11:
5:
3307:
3305:
3297:
3296:
3291:
3281:
3280:
3276:
3275:
3218:
3169:
3110:
3073:(4): 675–684.
3053:
3018:(3): 480–486.
3001:
2995:
2969:
2918:
2882:
2815:
2758:
2721:(3): 425–440.
2701:
2649:
2592:
2541:
2492:
2435:
2386:
2334:
2299:
2252:(2): 558–562.
2232:
2168:
2111:
2057:
2013:
1961:
1904:
1847:
1806:
1771:
1722:
1673:
1628:
1561:
1509:
1449:
1412:(4): 275–286.
1389:
1332:
1305:(1): 190–196.
1285:
1256:(1): 201–211.
1233:
1173:
1138:(1–3): 37–44.
1117:
1079:
1031:
991:
944:(1): 298–302.
921:
867:
794:
792:
789:
769:radioresistant
764:
761:
734:
731:
729:
726:
691:
688:
684:uterine cancer
672:ovarian cancer
631:
628:
608:
605:
603:
600:
595:
592:
557:
556:hPG80 receptor
554:
545:
542:
529:
526:
509:
506:
450:
447:
445:
442:
424:cells cultured
405:
402:
389:
386:
369:
366:
345:
342:
298:
297:Role in cancer
295:
208:
205:
173:
170:
126:
125:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
3306:
3295:
3292:
3290:
3287:
3286:
3284:
3271:
3267:
3262:
3257:
3253:
3249:
3245:
3241:
3237:
3233:
3229:
3222:
3219:
3214:
3210:
3206:
3202:
3197:
3192:
3188:
3184:
3180:
3173:
3170:
3165:
3161:
3156:
3151:
3147:
3143:
3138:
3133:
3129:
3125:
3121:
3114:
3111:
3106:
3102:
3098:
3094:
3090:
3086:
3081:
3076:
3072:
3068:
3064:
3057:
3054:
3049:
3045:
3041:
3037:
3033:
3029:
3025:
3021:
3017:
3013:
3005:
3002:
2998:
2992:
2988:
2984:
2980:
2973:
2970:
2965:
2961:
2957:
2953:
2949:
2945:
2941:
2937:
2933:
2929:
2922:
2919:
2914:
2910:
2906:
2902:
2898:
2894:
2886:
2883:
2878:
2874:
2870:
2866:
2861:
2856:
2852:
2848:
2843:
2838:
2834:
2830:
2826:
2819:
2816:
2811:
2807:
2802:
2797:
2793:
2789:
2785:
2781:
2777:
2773:
2769:
2762:
2759:
2754:
2750:
2746:
2742:
2738:
2734:
2729:
2724:
2720:
2716:
2712:
2705:
2702:
2697:
2693:
2689:
2685:
2681:
2677:
2673:
2669:
2665:
2661:
2653:
2650:
2645:
2641:
2636:
2631:
2627:
2623:
2619:
2615:
2611:
2607:
2603:
2596:
2593:
2588:
2584:
2580:
2576:
2572:
2568:
2564:
2560:
2556:
2552:
2545:
2542:
2537:
2533:
2529:
2525:
2520:
2515:
2511:
2507:
2503:
2496:
2493:
2488:
2484:
2479:
2474:
2470:
2466:
2462:
2458:
2454:
2450:
2446:
2439:
2436:
2431:
2427:
2423:
2419:
2414:
2409:
2405:
2401:
2397:
2390:
2387:
2382:
2378:
2374:
2370:
2365:
2360:
2356:
2352:
2348:
2341:
2339:
2335:
2330:
2326:
2322:
2318:
2314:
2310:
2303:
2300:
2295:
2291:
2286:
2281:
2277:
2273:
2268:
2263:
2259:
2255:
2251:
2247:
2243:
2236:
2233:
2228:
2222:
2214:
2210:
2206:
2202:
2198:
2194:
2190:
2186:
2179:
2172:
2169:
2164:
2160:
2155:
2150:
2146:
2142:
2138:
2134:
2130:
2126:
2122:
2115:
2112:
2107:
2103:
2099:
2095:
2091:
2087:
2083:
2079:
2075:
2071:
2064:
2062:
2058:
2053:
2049:
2045:
2041:
2037:
2033:
2029:
2025:
2017:
2014:
2009:
2005:
2001:
1997:
1993:
1989:
1985:
1981:
1977:
1973:
1965:
1962:
1957:
1953:
1949:
1945:
1941:
1937:
1932:
1927:
1923:
1919:
1915:
1908:
1905:
1900:
1896:
1891:
1886:
1882:
1878:
1874:
1870:
1866:
1862:
1858:
1851:
1848:
1843:
1839:
1834:
1829:
1825:
1821:
1817:
1810:
1807:
1802:
1798:
1794:
1790:
1786:
1782:
1775:
1772:
1767:
1763:
1759:
1755:
1750:
1745:
1741:
1737:
1733:
1726:
1723:
1718:
1714:
1710:
1706:
1701:
1696:
1692:
1688:
1684:
1677:
1674:
1669:
1665:
1659:
1651:
1647:
1643:
1635:
1633:
1629:
1624:
1620:
1616:
1612:
1608:
1604:
1599:
1594:
1590:
1586:
1582:
1574:
1572:
1570:
1568:
1566:
1562:
1557:
1553:
1549:
1545:
1540:
1535:
1531:
1527:
1523:
1516:
1514:
1510:
1505:
1501:
1497:
1493:
1489:
1485:
1480:
1475:
1471:
1467:
1463:
1456:
1454:
1450:
1445:
1441:
1436:
1431:
1427:
1423:
1419:
1415:
1411:
1407:
1403:
1396:
1394:
1390:
1385:
1381:
1377:
1373:
1368:
1363:
1359:
1355:
1351:
1343:
1341:
1339:
1337:
1333:
1328:
1324:
1320:
1316:
1312:
1308:
1304:
1300:
1292:
1290:
1286:
1281:
1277:
1273:
1269:
1264:
1259:
1255:
1251:
1250:Endocrinology
1247:
1240:
1238:
1234:
1229:
1225:
1220:
1215:
1211:
1207:
1203:
1199:
1195:
1191:
1187:
1180:
1178:
1174:
1169:
1165:
1161:
1157:
1153:
1149:
1145:
1141:
1137:
1133:
1126:
1124:
1122:
1118:
1113:
1109:
1105:
1101:
1097:
1093:
1086:
1084:
1080:
1075:
1071:
1067:
1063:
1059:
1055:
1051:
1047:
1040:
1038:
1036:
1032:
1027:
1023:
1019:
1015:
1011:
1007:
1000:
998:
996:
992:
987:
983:
978:
973:
969:
965:
960:
955:
951:
947:
943:
939:
935:
928:
926:
922:
917:
913:
909:
905:
900:
895:
891:
887:
883:
876:
874:
872:
868:
863:
859:
854:
849:
845:
841:
837:
833:
829:
825:
821:
814:
812:
810:
808:
806:
804:
802:
800:
796:
790:
788:
786:
782:
778:
774:
770:
762:
760:
757:
754:
751:
748:
746:
745:
740:
732:
727:
725:
723:
717:
713:
711:
706:
704:
700:
695:
689:
687:
685:
681:
677:
673:
669:
668:skin melanoma
665:
661:
657:
656:kidney cancer
653:
649:
645:
644:breast cancer
636:
629:
627:
625:
621:
617:
613:
606:
601:
599:
593:
591:
589:
583:
580:
576:
570:
566:
562:
555:
553:
551:
548:In 2012, the
543:
541:
539:
535:
527:
525:
523:
519:
515:
512:The oncogene
507:
505:
503:
498:
493:
491:
487:
483:
479:
475:
470:
468:
464:
460:
459:tumorigenesis
456:
449:Wnt and K-Ras
448:
443:
441:
439:
434:
430:
425:
422:
418:
410:
403:
401:
399:
395:
387:
385:
383:
379:
375:
367:
365:
363:
359:
355:
351:
343:
341:
338:
333:
331:
327:
322:
319:
315:
310:
308:
304:
296:
294:
290:
288:
284:
279:
276:
273:
271:
266:
264:
260:
255:
253:
248:
245:
243:
238:
236:
232:
231:tumorigenesis
227:
225:
221:
216:
214:
206:
204:
202:
198:
193:
191:
185:
183:
179:
171:
169:
167:
162:
158:
153:
150:
148:
144:
140:
136:
132:
122:
119:
111:
100:
97:
93:
90:
86:
83:
79:
76:
72:
69: –
68:
64:
63:Find sources:
57:
53:
49:
45:
41:
34:
27:
18:
17:
3235:
3231:
3221:
3186:
3182:
3172:
3127:
3123:
3113:
3070:
3066:
3056:
3015:
3011:
3004:
2978:
2972:
2931:
2927:
2921:
2896:
2892:
2885:
2832:
2828:
2818:
2775:
2771:
2761:
2718:
2714:
2704:
2663:
2659:
2652:
2609:
2605:
2595:
2554:
2550:
2544:
2509:
2505:
2495:
2452:
2448:
2438:
2403:
2399:
2389:
2354:
2350:
2312:
2308:
2302:
2249:
2245:
2235:
2221:cite journal
2188:
2184:
2171:
2128:
2124:
2114:
2073:
2069:
2027:
2023:
2016:
1975:
1971:
1964:
1921:
1917:
1907:
1867:(1): 90–95.
1864:
1860:
1850:
1823:
1819:
1809:
1784:
1780:
1774:
1739:
1735:
1725:
1690:
1686:
1676:
1644:. Elsevier.
1641:
1588:
1584:
1529:
1525:
1469:
1465:
1409:
1405:
1357:
1353:
1302:
1298:
1253:
1249:
1196:(1): 47–52.
1193:
1189:
1135:
1131:
1095:
1091:
1049:
1045:
1009:
1005:
941:
937:
889:
885:
827:
824:eBioMedicine
823:
766:
758:
755:
752:
749:
742:
739:chemotherapy
736:
718:
714:
707:
696:
693:
660:liver cancer
641:
620:liver tumors
610:
597:
584:
571:
567:
563:
559:
547:
537:
531:
521:
511:
496:
494:
489:
485:
471:
462:
452:
415:
391:
371:
347:
340:carcinogen.
336:
334:
329:
325:
323:
311:
300:
291:
280:
277:
274:
267:
256:
251:
249:
246:
239:
235:colon cancer
228:
224:colon cancer
217:
210:
194:
186:
175:
154:
151:
130:
129:
114:
105:
95:
88:
81:
74:
62:
1826:(4): A484.
779:damage and
534:colon tumor
182:amino acids
172:Terminology
108:August 2020
44:independent
3294:Biomarkers
3283:Categories
3232:Oncotarget
3130:(1): 531.
3124:BMC Cancer
2829:Oncotarget
2131:(1): 1–5.
830:: 102574.
791:References
650:, stomach/
438:metastases
394:metastasis
283:antibodies
244:patients.
201:progastrin
178:progastrin
139:progastrin
135:progastrin
78:newspapers
52:redirected
3252:1949-2553
3205:0815-9319
3146:1471-2407
3089:1940-6207
3032:0815-9319
2948:0007-1323
2913:0016-5085
2899:: A1219.
2851:1949-2553
2792:0016-5085
2737:0950-9232
2680:0193-1857
2626:0167-0115
2571:0193-1857
2528:0008-5472
2469:0950-9232
2422:0008-5472
2373:0008-5472
2329:0016-5085
2276:0027-8424
2205:997679353
2145:0007-0920
2090:0179-1958
2044:0193-1857
1992:0193-1857
1940:0008-543X
1881:0017-5749
1842:0016-5085
1801:0016-5085
1758:0016-5085
1709:0016-5085
1658:cite book
1650:894059948
1607:1078-0432
1548:0008-5472
1488:0950-9232
1426:0735-7907
1376:0016-5085
1319:0006-291X
1272:0013-7227
1210:0017-5749
1152:0167-0115
1104:0008-5472
1066:0193-1857
1018:0008-5472
968:0027-8424
844:2352-3964
787:and ERK.
781:apoptosis
710:biomarker
699:carcinoma
602:Screening
588:organoids
575:NF-kappaB
382:apoptosis
378:caspase 3
374:caspase 9
358:xenograft
318:paracrine
314:autocrine
143:digestion
42:that are
3289:Oncology
3270:28938581
3213:20796153
3164:24209454
3097:22366915
3048:25335053
3040:24716212
2964:24292877
2956:10931047
2869:28380450
2810:20826156
2753:10850923
2745:16832341
2715:Oncogene
2696:36435882
2688:15486344
2644:18674570
2587:36872664
2579:12388191
2536:19622776
2487:18521082
2449:Oncogene
2430:17671195
2381:15805277
2213:12761477
2163:26110974
2098:28432443
2052:12881229
2008:19068321
2000:10712258
1948:15022301
1623:22085894
1615:28600477
1556:27197176
1504:20661274
1496:25109333
1466:Oncogene
1444:22480191
1384:17920061
1327:16139800
1280:12488346
1228:11115822
1168:26008211
1160:11033051
916:21931954
908:12615962
862:31877416
429:antibody
265:models.
192:.
3261:5601677
3155:3829387
2877:4727270
2860:5522213
2801:3031715
2635:2630224
2478:2891442
2294:2105487
2254:Bibcode
2154:4647531
2106:4574556
1956:2139822
1899:8432459
1890:1374107
1766:7557079
1717:8462798
1435:3697930
1219:1728168
1112:8797575
1074:8166285
1026:8467501
986:2296587
946:Bibcode
853:6938867
579:HEK-293
237:cells.
226:cells.
220:ovarian
215:cells.
190:gastrin
166:gastrin
161:peptide
92:scholar
67:"HPG80"
56:deleted
3268:
3258:
3250:
3211:
3203:
3162:
3152:
3144:
3103:
3095:
3087:
3046:
3038:
3030:
2993:
2962:
2954:
2946:
2911:
2875:
2867:
2857:
2849:
2808:
2798:
2790:
2751:
2743:
2735:
2694:
2686:
2678:
2642:
2632:
2624:
2585:
2577:
2569:
2534:
2526:
2485:
2475:
2467:
2428:
2420:
2379:
2371:
2327:
2292:
2282:
2274:
2211:
2203:
2161:
2151:
2143:
2104:
2096:
2088:
2050:
2042:
2006:
1998:
1990:
1954:
1946:
1938:
1918:Cancer
1897:
1887:
1879:
1840:
1799:
1764:
1756:
1715:
1707:
1648:
1621:
1613:
1605:
1554:
1546:
1502:
1494:
1486:
1442:
1432:
1424:
1382:
1374:
1325:
1317:
1278:
1270:
1226:
1216:
1208:
1166:
1158:
1150:
1110:
1102:
1072:
1064:
1024:
1016:
984:
974:
966:
914:
906:
860:
850:
842:
332:gene.
268:2012:
159:. The
157:cancer
94:
87:
80:
73:
65:
48:merged
3105:53420
3101:S2CID
3044:S2CID
2960:S2CID
2873:S2CID
2749:S2CID
2692:S2CID
2583:S2CID
2285:53304
2181:(PDF)
2102:S2CID
2004:S2CID
1952:S2CID
1619:S2CID
1500:S2CID
1164:S2CID
977:53250
912:S2CID
528:NOTCH
502:SMAD4
478:K-Ras
474:K-Ras
356:) in
354:shRNA
147:tumor
131:hPG80
99:JSTOR
85:books
54:, or
3266:PMID
3248:ISSN
3209:PMID
3201:ISSN
3160:PMID
3142:ISSN
3093:PMID
3085:ISSN
3036:PMID
3028:ISSN
2991:ISBN
2952:PMID
2944:ISSN
2909:ISSN
2865:PMID
2847:ISSN
2806:PMID
2788:ISSN
2741:PMID
2733:ISSN
2684:PMID
2676:ISSN
2640:PMID
2622:ISSN
2575:PMID
2567:ISSN
2532:PMID
2524:ISSN
2483:PMID
2465:ISSN
2426:PMID
2418:ISSN
2377:PMID
2369:ISSN
2325:ISSN
2290:PMID
2272:ISSN
2227:link
2209:PMID
2201:OCLC
2159:PMID
2141:ISSN
2094:PMID
2086:ISSN
2048:PMID
2040:ISSN
1996:PMID
1988:ISSN
1944:PMID
1936:ISSN
1895:PMID
1877:ISSN
1838:ISSN
1797:ISSN
1762:PMID
1754:ISSN
1713:PMID
1705:ISSN
1668:link
1664:link
1646:OCLC
1611:PMID
1603:ISSN
1552:PMID
1544:ISSN
1492:PMID
1484:ISSN
1440:PMID
1422:ISSN
1380:PMID
1372:ISSN
1323:PMID
1315:ISSN
1276:PMID
1268:ISSN
1224:PMID
1206:ISSN
1156:PMID
1148:ISSN
1108:PMID
1100:ISSN
1070:PMID
1062:ISSN
1022:PMID
1014:ISSN
982:PMID
964:ISSN
904:PMID
858:PMID
840:ISSN
744:KRAS
682:and
622:and
544:p-53
538:JAG1
522:GAST
514:pp60
497:GAST
490:GAST
486:GAST
482:mRNA
463:GAST
398:mRNA
376:and
337:GAST
330:GAST
326:GAST
316:and
252:GAST
222:and
71:news
3256:PMC
3240:doi
3191:doi
3150:PMC
3132:doi
3075:doi
3020:doi
2983:doi
2936:doi
2901:doi
2897:114
2855:PMC
2837:doi
2796:PMC
2780:doi
2776:140
2723:doi
2668:doi
2664:288
2630:PMC
2614:doi
2610:151
2559:doi
2555:284
2514:doi
2473:PMC
2457:doi
2408:doi
2359:doi
2317:doi
2313:150
2280:PMC
2262:doi
2193:doi
2189:141
2149:PMC
2133:doi
2129:113
2078:doi
2032:doi
2028:285
1980:doi
1976:278
1926:doi
1922:100
1885:PMC
1869:doi
1861:Gut
1828:doi
1824:108
1789:doi
1785:108
1744:doi
1740:109
1695:doi
1691:104
1593:doi
1534:doi
1474:doi
1430:PMC
1414:doi
1362:doi
1358:133
1307:doi
1303:336
1258:doi
1254:144
1214:PMC
1198:doi
1190:Gut
1140:doi
1054:doi
1050:266
972:PMC
954:doi
894:doi
890:116
848:PMC
832:doi
785:Akt
777:DNA
550:P53
467:Wnt
270:p53
259:Wnt
233:of
3285::
3264:.
3254:.
3246:.
3234:.
3230:.
3207:.
3199:.
3187:25
3185:.
3181:.
3158:.
3148:.
3140:.
3128:13
3126:.
3122:.
3099:.
3091:.
3083:.
3069:.
3065:.
3042:.
3034:.
3026:.
3016:29
3014:.
2989:,
2958:.
2950:.
2942:.
2932:87
2930:.
2907:.
2895:.
2871:.
2863:.
2853:.
2845:.
2831:.
2827:.
2804:.
2794:.
2786:.
2774:.
2770:.
2747:.
2739:.
2731:.
2719:26
2717:.
2713:.
2690:.
2682:.
2674:.
2662:.
2638:.
2628:.
2620:.
2608:.
2604:.
2581:.
2573:.
2565:.
2553:.
2530:.
2522:.
2510:69
2508:.
2504:.
2481:.
2471:.
2463:.
2453:27
2451:.
2447:.
2424:.
2416:.
2404:67
2402:.
2398:.
2375:.
2367:.
2355:65
2353:.
2349:.
2337:^
2323:.
2311:.
2288:.
2278:.
2270:.
2260:.
2250:87
2248:.
2244:.
2223:}}
2219:{{
2207:.
2199:.
2187:.
2183:.
2157:.
2147:.
2139:.
2127:.
2123:.
2100:.
2092:.
2084:.
2074:32
2072:.
2060:^
2046:.
2038:.
2026:.
2002:.
1994:.
1986:.
1974:.
1950:.
1942:.
1934:.
1920:.
1916:.
1893:.
1883:.
1875:.
1865:34
1863:.
1859:.
1836:.
1822:.
1818:.
1795:.
1783:.
1760:.
1752:.
1738:.
1734:.
1711:.
1703:.
1689:.
1685:.
1660:}}
1656:{{
1631:^
1617:.
1609:.
1601:.
1589:23
1587:.
1583:.
1564:^
1550:.
1542:.
1530:76
1528:.
1524:.
1512:^
1498:.
1490:.
1482:.
1470:34
1468:.
1464:.
1452:^
1438:.
1428:.
1420:.
1410:30
1408:.
1404:.
1392:^
1378:.
1370:.
1356:.
1352:.
1335:^
1321:.
1313:.
1301:.
1288:^
1274:.
1266:.
1252:.
1248:.
1236:^
1222:.
1212:.
1204:.
1194:48
1192:.
1188:.
1176:^
1162:.
1154:.
1146:.
1136:93
1134:.
1120:^
1106:.
1096:56
1094:.
1082:^
1068:.
1060:.
1048:.
1034:^
1020:.
1010:53
1008:.
994:^
980:.
970:.
962:.
952:.
942:87
940:.
936:.
924:^
910:.
902:.
888:.
884:.
870:^
856:.
846:.
838:.
828:51
826:.
822:.
798:^
678:,
674:,
670:,
666:,
662:,
658:,
654:,
646:,
618:,
461:.
384:.
364:.
184:.
168:.
50:,
3272:.
3242::
3236:8
3215:.
3193::
3166:.
3134::
3107:.
3077::
3071:5
3050:.
3022::
2985::
2966:.
2938::
2915:.
2903::
2879:.
2839::
2833:8
2812:.
2782::
2755:.
2725::
2698:.
2670::
2646:.
2616::
2589:.
2561::
2538:.
2516::
2489:.
2459::
2432:.
2410::
2383:.
2361::
2331:.
2319::
2296:.
2264::
2256::
2229:)
2215:.
2195::
2165:.
2135::
2108:.
2080::
2054:.
2034::
2010:.
1982::
1958:.
1928::
1901:.
1871::
1844:.
1830::
1803:.
1791::
1768:.
1746::
1719:.
1697::
1670:)
1652:.
1625:.
1595::
1558:.
1536::
1506:.
1476::
1446:.
1416::
1386:.
1364::
1329:.
1309::
1282:.
1260::
1230:.
1200::
1170:.
1142::
1114:.
1076:.
1056::
1028:.
988:.
956::
948::
918:.
896::
864:.
834::
121:)
115:(
110:)
106:(
96:·
89:·
82:·
75:·
58:.
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.